Sign In
Buy STXS
$1.84
-0.130 (-6.60%)
At Close: Jun 03, 2026
Imminent Magic Catheter Approval Will Spike Stereotaxis Stock
06:48am, Sunday, 12'th Nov 2023
Stereotaxis was forced to do a human trial for its Magic catheter before it can get CE Mark. This is starting in a few weeks. Stereotaxis will soon submit a PMA for FDA approval of the Magic catheter
Stereotaxis to Report Third Quarter 2023 Financial Results on November 9, 2023
09:05am, Tuesday, 17'th Oct 2023
ST. LOUIS, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will r
Stereotaxis, Inc. (STXS) Q2 2023 Earnings Call Transcript
04:29pm, Thursday, 10'th Aug 2023
Stereotaxis, Inc. (NYSE:STXS ) Q2 2023 Earnings Conference Call August 10, 2023 10:00 AM ET Company Participants David Fischel - Chairman & Chief Executive Officer Kimberly Peery - Chief Financial Off
Stereotaxis to Report Second Quarter 2023 Financial Results on August 10, 2023
01:58am, Saturday, 15'th Jul 2023
ST. LOUIS, July 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will r
Down -32.11% in 4 Weeks, Here's Why You Should You Buy the Dip in Stereotaxis Inc. (STXS)
11:03am, Tuesday, 11'th Jul 2023
Stereotaxis Inc. (STXS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings es
Stereotaxis to Participate in 20th Annual Craig-Hallum Institutional Investor Conference
08:56am, Thursday, 25'th May 2023
ST. LOUIS, May 25, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fisc
5 Top Penny Stocks To Watch Today; Time To Buy?
12:57pm, Friday, 19'th May 2023
5 hot penny stocks to watch right now. The post 5 Top Penny Stocks To Watch Today; Time To Buy?
Stereotaxis to Report First Quarter 2023 Financial Results on May 9, 2023
09:05am, Tuesday, 18'th Apr 2023
ST. LOUIS, April 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will
Stereotaxis, Inc. (STXS) Q4 2022 Earnings Call Transcript
01:37pm, Friday, 03'rd Mar 2023
Stereotaxis, Inc. (NYSE:STXS ) Q4 2022 Earnings Conference Call March 3, 2023 10:00 AM ET Company Participants David Fischel - CEO & Chairman Kimberly Peery - CFO & Secretary Conference Call Participa
Stereotaxis to Present at Cowen 43rd Annual Health Care Conference
09:03am, Tuesday, 21'st Feb 2023
ST. LOUIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fis
Catalysts Are Coming Soon For Stereotaxis
12:11pm, Wednesday, 15'th Feb 2023
Stereotaxis, Inc. stock fell in 2022 because of new product delays and weak new orders. These delays and disappointing new orders were caused by macro headwinds that are abating. There are many cataly
Stereotaxis to Report Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023
09:05am, Thursday, 02'nd Feb 2023
ST. LOUIS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will r
Stereotaxis to Report Third Quarter Financial Results on November 10, 2022
09:05am, Thursday, 20'th Oct 2022
ST. LOUIS, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will r
Stereotaxis, Inc. (STXS) CEO David Fischel on Q2 2022 Results - Earnings Call Transcript
03:39pm, Tuesday, 09'th Aug 2022
Stereotaxis, Inc. (NYSE:STXS ) Q2 2022 Earnings Conference Call August 9, 2022 10:00 AM ET Company Representatives David Fischel - Chairman, Chief Executive Officer Kim Peery - Chief Financial Officer
Stereotaxis to Report Second Quarter Financial Results on August 9, 2022
09:00am, Tuesday, 19'th Jul 2022
ST. LOUIS, July 19, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will r
